The role of insulin detemir in overweight type 2 diabetes management. - Wikidata - awgldk - TriplyDB

The role of insulin detemir in overweight type 2 diabetes management.

The role of insulin detemir in overweight type 2 diabetes management.

http://www.wikidata.org/entity/Q37248234

about

An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog.

P2860

Q33902616-6F95BB0E-8090-41FC-B386-8A64BBD03DEE

P2860

The role of insulin detemir in overweight type 2 diabetes management.

http://www.wikidata.org/entity/Q37248234

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The role of insulin detemir in overweight type 2 diabetes management.

@ast

The role of insulin detemir in overweight type 2 diabetes management.

@en

The role of insulin detemir in overweight type 2 diabetes management.

@nl

type

label

The role of insulin detemir in overweight type 2 diabetes management.

@ast

The role of insulin detemir in overweight type 2 diabetes management.

@en

The role of insulin detemir in overweight type 2 diabetes management.

@nl

prefLabel

The role of insulin detemir in overweight type 2 diabetes management.

@ast

The role of insulin detemir in overweight type 2 diabetes management.

@en

The role of insulin detemir in overweight type 2 diabetes management.

@nl

P1433

Q37248234-49721AEF-6A65-439C-84D6-97A311208949

P1476

Q37248234-A51E5A6A-E6BC-41DE-8CE3-DA4EA6C8DA90

P2093

Q37248234-47EECBEE-28B9-471F-84A0-59BDEC994F8B

Q37248234-4A6AD52E-85F8-4D8A-99D9-104582215C72

Q37248234-E61B6BF9-1E9F-4B3F-9D6D-5D5689262447

P2860

Q37248234-0B6575AD-323F-45BF-B509-13614D3AA122

Q37248234-0E3FBCED-B6C8-44FB-856D-9E671BE9B7DF

Q37248234-1CB0E54F-6D19-4B1F-A8B7-3EB8A6C1CAB5

Q37248234-1E81F9B5-98C5-4478-93B3-E31EEC7A41E3

Q37248234-26EED19A-353A-47B2-A19D-62124BC8E0C0

Q37248234-344DD89D-045E-421A-81C8-2B5FD91457E7

Q37248234-358B0367-7879-450D-A65D-E7BD9838F81A

Q37248234-41E7AF9D-AFAE-4410-A534-BECBD2FA151A

Q37248234-4C2E4E70-F09C-4F1D-8475-13DDCEF2E7F6

Q37248234-4C53AC52-5FE2-4820-82BE-18DA2E5E75DF

P304

Q37248234-3F1A175A-DAC2-485D-8D48-1D33A4FE31B1

P31

Q37248234-247267E2-1F9A-49B8-AC62-D6126FCEAE26

P356

Q37248234-68E61764-E478-4B7C-A601-6042B16B737D

P407

Q37248234-3D4EDBB7-727B-4556-B560-08EA8771D6CF

P433

Q37248234-D3E9EE93-07C8-44B5-8F26-B11B3226570C

P478

Q37248234-B672B0AF-4D88-4FFA-A113-469B7DAC0075

P577

Q37248234-A5E086B6-37B9-4E61-A2B8-E13942795319

P698

Q37248234-A5C2D313-C181-4307-9C9F-35431DE7E31C

P921

Q37248234-2b8ac534-2070-4a78-a2e2-045c92aaed75

Q37248234-55185C69-F3F1-4AE8-B06A-6036BEEB9F25

Q37248234-8DA00794-5046-4959-B5D3-0EDAAAE92454

Q37248234-E15C2DCE-83AC-424F-9616-6DEECF972191

Q37248234-E84B8787-DC54-4938-90A2-295EFEA60025

Q37248234-EA32E05D-5023-4C2D-BB75-E7A242FFE967

P932

Q37248234-E481545C-4B83-4AD7-AC89-0AEEA7F6FF40

P356

P1433

Vascular Health and Risk Management

P1476

The role of insulin detemir in overweight type 2 diabetes management

@en

P2093

Handrean Soran

http://www.w3.org/2001/XMLSchema#string

Naveed Younis

http://www.w3.org/2001/XMLSchema#string

Yared N Demssie

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus

Crystal structure of a prolonged-acting insulin with albumin-binding properties

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

10-year follow-up of intensive glucose control in type 2 diabetes

Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002.

The clinical implications of insulin resistance.

Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity.

Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.

Variability of insulin absorption and insulin action.

P304

553-560

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/VHRM.S4326

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19590589

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

maturity-onset diabetes of the young

P932

2704896

http://www.w3.org/2001/XMLSchema#string